Abstract:Acute Pancreatitis (AP) is associated with high mortality and current treatment options are limited to supportive care. We found that blockade of activin A (activin) in mice improves outcomes in two murine models of AP. To test the hypothesis that activin is produced early in response to pancreatitis and is maintained throughout disease progression to stimulate immune cells, we first performed digital spatial profiling (DSP) of human chronic pancreatitis (CP) patient tissue. Then, transwell migration assays using RAW264.7 mouse macrophages and qPCR analysis of "neutrophil-like" HL-60 cells were used for functional correlation. Immunofluorescence and western blots on cerulein-induced pancreatitis samples from pancreatic acinar cell-specific Kras knock-in ( Ptf1aCre ER TM; LSL-Kras G12D ) and functional WT Ptf1aCre ER TM mouse lines mimicking AP and CP to allow for in vivo confirmation. Our data suggest activin promotes neutrophil and macrophage activation both in situ and in vitro, while pancreatic activin production is increased as early as 1 h in response to pancreatitis and is maintained throughout CP in vivo. Taken together, activin is produced early in response to pancreatitis and is maintained throughout disease progression to promote neutrophil and macrophage activation.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the role of activin A in the disease progression of acute pancreatitis (AP) and chronic pancreatitis (CP). Specifically, the researchers hope to verify the following hypothesis: activin A is produced in the early stage of acute pancreatitis and persists throughout the disease progression process to stimulate the activation of immune cells (such as neutrophils and macrophages), thereby exacerbating the inflammatory response. In addition, the study also explored whether activin A can be used as a potential target for the treatment of acute pancreatitis and chronic pancreatitis. ### Research Background - **Acute Pancreatitis (AP)**: It is an inflammatory disease that causes the destruction of pancreatic acinar cells. Its incidence has increased significantly in the past few decades, but the current treatment options are limited to supportive care, and the mortality rate is high. - **Chronic Pancreatitis (CP)**: Some patients with acute pancreatitis will develop chronic pancreatitis, further increasing the risk of pancreatic ductal adenocarcinoma (PDAC). - **Activin A**: It is a protein belonging to the transforming growth factor - β (TGF - β) superfamily and is known to play a key role in the induction of inflammation, cancer, and other cytokines. Studies have found that the serum activin A level in patients with acute pancreatitis is elevated, and a high level of activin A is associated with a longer hospital stay and a higher disease severity. ### Research Methods 1. **Digital Spatial Profiling (DSP)**: Identify the cell - signal characteristics co - localized with activin A by performing digital spatial profiling on tissue samples from patients with chronic pancreatitis. 2. **In vitro experiments**: - Use RAW264.7 macrophages to conduct a transwell migration experiment to verify the effect of activin A on macrophage migration. - Use HL - 60 cells (differentiated into neutrophil - like cells) for real - time quantitative PCR (qPCR) analysis to verify the effect of activin A on neutrophil activation. 3. **In vivo experiments**: - Use two different mouse models (acute pancreatitis and chronic - inflammation - assisted pancreatic ductal adenocarcinoma models), and verify the expression of activin A in the early stage of pancreatitis and throughout the disease process through immunofluorescence staining and Western Blot analysis. ### Main Findings - **Digital Spatial Profiling**: In the tissue samples of patients with chronic pancreatitis, the activin A co - localization area showed a significant up - regulation of immune cell markers (such as CD45, CD66b, CD68, etc.) and MAPK pathway markers. - **In vitro experiments**: Activin A significantly enhanced the migration ability of RAW264.7 macrophages and the expression of neutrophil markers (such as CD66b) in HL - 60 cells. - **In vivo experiments**: In the mouse models, the expression of activin A increased significantly in the early stage (1 hour) of acute pancreatitis and maintained a high level throughout the disease process, especially more obvious in mice expressing the oncogene Kras. ### Conclusion The research results show that activin A is produced in the early stage of acute pancreatitis and persists throughout the disease progression process, exacerbating the inflammatory response by promoting the activation of neutrophils and macrophages. These findings suggest that activin A may be a potential target for the treatment of acute pancreatitis and chronic pancreatitis.

Activin A signaling stimulates neutrophil activation and macrophage migration in pancreatitis

P2RX1-Involved Glycolytic Metabolism Supports Neutrophil Activation in Acute Pancreatitis

Identification of novel immune-related targets mediating disease progression in acute pancreatitis

Role of Nuclear Factor-Kappab, Reactive Oxygen Species and Cellular Signaling in the Early Phase of Acute Pancreatitis.

Immune Status and Inflammatory Response Differ Locally and Systemically in Severe Acute Pancreatitis.

Myeloid‐specific Dopamine D2 Receptor Signalling Controls Inflammation in Acute Pancreatitis Via Inhibiting M1 Macrophage

Cellular and Molecular Events in Acute Pancreatitis

PD-1/PDL1 Blockade Exacerbates Pancreatic Damage and Immune Response in a Mouse Model of Acute Pancreatitis.

Influence of Platelet Activating Factor on Expression of Adhesion Molecules in Experimental Pancreatitis

Neutrophil-derived IL-10 increases CVB3-induced acute pancreatitis pathology via suppressing CD8+T cell activation while increasing macrophage STAT3-IL-6 cascade

Expression of Macrophage Migration Inhibitory Factor and Its Significance in Lung Tissue of Acute Pancreatitis

MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10

Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injury

Sphingosine 1-phosphate receptor 2 mediated early stages of pancreatic and systemic inflammatory responses via NF-kappa B activation in acute pancreatitis

Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation

Alternatively Activated Macrophages Promote Pancreatic Fibrosis in Chronic Pancreatitis

Induction of Chronic Pancreatitis by Pancreatic Duct Ligation Activates BMP2, Apelin, and PTHrP Expression in Mice

Comparative transcriptomic analysis reveals the molecular changes of acute pancreatitis in experimental models

Acute Pancreatitis Signals Activation of Apoptosis-Associated and Survival Genes in Mice

Influence of Mast Cells on the Expression of Adhesion Molecules on Circulating and Migrating Leukocytes in Acute Pancreatitis-Associated Lung Injury

Activation of Α7nach Receptor Protects Against Acute Pancreatitis Through Enhancing TFEB-regulated Autophagy